New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates.

Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria A, Haning W, Della Grotta S, Strauss A, Lester BM, Huestis MA. New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates. Clin Chem. 2010 May; 56(5):856-60.

View in: PubMed

subject areas

Central Nervous System Stimulants
Female
Humans
Infant, Newborn
Meconium
Methamphetamine
Pregnancy
Substance Abuse Detection

authors with profiles

William Haning, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support